4//SEC Filing
Anthera Pharmaceuticals Inc 4
Accession 0001214659-13-003594
CIK 0001316175operating
Filed
Jun 25, 8:00 PM ET
Accepted
Jun 26, 5:24 PM ET
Size
8.6 KB
Accession
0001214659-13-003594
Insider Transaction Report
Form 4
Thompson David E.
Director
Transactions
- Purchase
Common Stock
2013-06-24$0.53/sh+100,000$53,000→ 128,201 total(indirect: By Trust)
Issuer
Anthera Pharmaceuticals Inc
CIK 0001316175
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001316175
Filing Metadata
- Form type
- 4
- Filed
- Jun 25, 8:00 PM ET
- Accepted
- Jun 26, 5:24 PM ET
- Size
- 8.6 KB